Literature DB >> 33580027

Recapitulating kidney development in vitro by priming and differentiating mouse embryonic stem cells in monolayers.

Theresa Chow1,2, Frances T M Wong2, Claudio Monetti1, Andras Nagy1,3,4, Brian Cox2,3, Ian M Rogers5,6,7.   

Abstract

In order to harness the potential of pluripotent stem cells, we need to understand how to differentiate them to our target cell types. Here, we developed a protocol to differentiate mouse embryonic stem cells (ESCs) to renal progenitors in a step-wise manner. Microarrays were used to track the transcriptional changes at each stage of differentiation and we observed that genes associated with metanephros, ureteric bud, and blood vessel development were significantly upregulated as the cells differentiated towards renal progenitors. Priming the ESCs and optimizing seeding cell density and growth factor concentrations helped improve differentiation efficiency. Organoids were used to determine the developmental potential of the renal progenitor cells. Aggregated renal progenitors gave rise to organoids consisting of LTL+/E-cadherin+ proximal tubules, cytokeratin+ ureteric bud-derived tubules, and extracellular matrix proteins secreted by the cells themselves. Over-expression of key kidney developmental genes, Pax2, Six1, Eya1, and Hox11 paralogs, during differentiation did not improve differentiation efficiency. Altogether, we developed a protocol to differentiate mouse ESCs in a manner that recapitulates embryonic kidney development and showed that precise gene regulation is essential for proper differentiation to occur.

Year:  2020        PMID: 33580027     DOI: 10.1038/s41536-020-0092-5

Source DB:  PubMed          Journal:  NPJ Regen Med        ISSN: 2057-3995


  49 in total

1.  Activin a produced by ureteric bud is a differentiation factor for metanephric mesenchyme.

Authors:  Akito Maeshima; Shin Yamashita; Kyoko Maeshima; Itaru Kojima; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

2.  Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney.

Authors:  M Takasato; P X Er; M Becroft; J M Vanslambrouck; E G Stanley; A G Elefanty; M H Little
Journal:  Nat Cell Biol       Date:  2013-12-15       Impact factor: 28.824

Review 3.  The role of the activin-follistatin system in the developmental and regeneration processes of the kidney.

Authors:  A Maeshima; Y Nojima; I Kojima
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

4.  Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia.

Authors:  P X Xu; J Adams; H Peters; M C Brown; S Heaney; R Maas
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

5.  Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia.

Authors:  Doyeob Kim; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 10.121

6.  Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling.

Authors:  Tomoyuki Sumi; Norihiro Tsuneyoshi; Norio Nakatsuji; Hirofumi Suemori
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

Review 7.  Cell and molecular biology of kidney development.

Authors:  Kimberly J Reidy; Norman D Rosenblum
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

8.  Six1 is required for the early organogenesis of mammalian kidney.

Authors:  Pin-Xian Xu; Weiming Zheng; Li Huang; Pascal Maire; Christine Laclef; Derek Silvius
Journal:  Development       Date:  2003-07       Impact factor: 6.868

9.  Hox11 paralogous genes are essential for metanephric kidney induction.

Authors:  Deneen M Wellik; Patrick J Hawkes; Mario R Capecchi
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

10.  Pax-2 controls multiple steps of urogenital development.

Authors:  M Torres; E Gómez-Pardo; G R Dressler; P Gruss
Journal:  Development       Date:  1995-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.